K Paul Stoller, FACHM Fides constantis, Dilectio absoluta, Vita aeterna Hyperbaric & Integrative Medicine
Could combining psilocybin, the groundbreaking psychedelic therapy, with bioidentical oxytocin, the “bonding hormone,” revolutionize the treatment of PTSD and depression? Psilocybin has shown a 71% success rate in clinical trials, earning FDA recognition as a “breakthrough therapy” for treatment-resistant depression. Oxytocin, known for reducing fear and enhancing emotional connection, could amplify the healing potential of psilocybin. While speculative, this innovative combination could address both the neurological and emotional dimensions of trauma. Watch now to explore the science, possibilities, and future of mental health treatment.